Skip to main content
AMPH
NASDAQ Life Sciences

FDA Approves Amphastar's REXTOVY Naloxone Nasal Spray for OTC Use

Tom Rudovsky · Reported by Reuters
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$19.85
Mkt Cap
$869.071M
52W Low
$16.645
52W High
$31.264
52W Position info
19% above low
Off High info
37% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

AMPH sits 19% above its 52-week low of $16.645.

Summary

The FDA has approved Amphastar Pharmaceuticals' REXTOVY 4 mg naloxone nasal spray for over-the-counter (OTC) use, significantly broadening access for emergency opioid overdose treatment. This regulatory win is a major positive for Amphastar, as it is expected to substantially expand the market and potential sales volume for REXTOVY. This development offers a positive counter-narrative following the company's recent Q1 2026 financial results, which reported a 75% decline in net income.

At the time of this announcement, AMPH was trading at $19.85 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $869.1M. The 52-week trading range was $16.65 to $31.26. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

AMPH - Latest Insights

AMPH
Nov 05, 2026, 4:40 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $30.10
Real-time Price: $28.26 info
Change: -$1.84 (-6%) info
Market Cap: $1.205B info
AMPH
Nov 05, 2026, 4:26 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $30.10
Real-time Price: $28.26 info
Change: -$1.84 (-6%) info
Market Cap: $1.205B info
AMPH
Nov 05, 2026, 4:10 PM EST
Source: PR Newswire
Importance Score:
7
Price at Filing: $27.66
Real-time Price: $28.26 info
Change: +$0.6003 (+2%) info
Market Cap: $1.205B info
AMPH
Aug 06, 2026, 4:50 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $20.35
Real-time Price: $28.26 info
Change: +$7.91 (+39%) info
Market Cap: $1.205B info
AMPH
Aug 06, 2026, 4:05 PM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $20.35
Real-time Price: $28.26 info
Change: +$7.91 (+39%) info
Market Cap: $1.205B info